Trends in antifungal susceptibility testing using CLSI reference and commercial methods

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Expert Review of Anti-Infective Therapy

• Publication date

  2009-01-30

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1586/14787210.7.1.107PMID 19622060
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Method for antifungal disk diffusion susceptibility testing of yeasts : Approved guideline

  2009cited by this paper
• Reference method for broth dilution antifungal susceptibility testing of filamentous fungi : Approved standard

  2008cited by this paper
• Validation of 24-Hour Fluconazole MIC Readings versus the CLSI 48-Hour Broth Microdilution Reference Method: Results from a Global Candida Antifungal Surveillance Program

  2008cited by this paper
• Comparison of Neo-Sensitabs Tablet Diffusion Assay with CLSI Broth Microdilution M38-A and Disk Diffusion Methods for Testing Susceptibility of Filamentous Fungi with Amphotericin B, Caspofungin, Itraconazole, Posaconazole, and Voriconazole

  2008cited by this paper
• Rationale for Reading Fluconazole MICs at 24 Hours Rather than 48 Hours When Testing Candida spp. by the CLSI M27-A2 Standard Method

  2008cited by this paper
• Reference method for broth dilution antifungal susceptibility testing of yeasts : Approved standard

  2008cited by this paper
• Correlation of MIC with Outcome for Candida Species Tested against Caspofungin, Anidulafungin, and Micafungin: Analysis and Proposal for Interpretive MIC Breakpoints

  2008cited by this paper
• Caspofungin Disk Diffusion Breakpoints and Quality Control

  2008cited by this paper
• Establishing In Vitro-In Vivo Correlations for Aspergillus fumigatus: the Challenge of Azoles versus Echinocandins

  2008cited by this paper
• Multicenter Comparison of the VITEK 2 Yeast Susceptibility Test with the CLSI Broth Microdilution Reference Method for Testing Fluconazole against Candida spp

  2007cited by this paper
• Antimicrobial Susceptibility Testing Protocols

  2007cited by this paper
• Acquired resistance to echinocandins in Candida albicans: case report and review.

  2007cited by this paper
• Differential Fungicidal Activities of Amphotericin B and Voriconazole against Aspergillus Species Determined by Microbroth Methodology

  2007cited by this paper
• Quality Control and Reference Guidelines for CLSI Broth Microdilution Method (M38-A Document) for Susceptibility Testing of Anidulafungin against Molds

  2007cited by this paper
• Comparative Evaluation of Etest and Sensititre YeastOne Panels against the Clinical and Laboratory Standards Institute M27-A2 Reference Broth Microdilution Method for Testing Candida Susceptibility to Seven Antifungal Agents

  2007cited by this paper
• Multicenter Comparison of the VITEK 2 Antifungal Susceptibility Test with the CLSI Broth Microdilution Reference Method for Testing Amphotericin B, Flucytosine, and Voriconazole against Candida spp

  2007cited by this paper
• Correlation of Neo-Sensitabs Tablet Diffusion Assay Results on Three Different Agar Media with CLSI Broth Microdilution M27-A2 and Disk Diffusion M44-A Results for Testing Susceptibilities of Candida spp. and Cryptococcus neoformans to Amphotericin B, Caspofungin, Fluconazole, Itraconazole, and Vori

  2007cited by this paper
• Selection of a Surrogate Agent (Fluconazole or Voriconazole) for Initial Susceptibility Testing of Posaconazole against Candida spp.: Results from a Global Antifungal Surveillance Program

  2007cited by this paper
• Antifungal Susceptibility Testing of Yeasts

  2007cited by this paper
• Multicenter Evaluation of a New Disk Agar Diffusion Method for Susceptibility Testing of Filamentous Fungi with Voriconazole, Posaconazole, Itraconazole, Amphotericin B, and Caspofungin

  2007cited by this paper
• Use of Fluconazole as a Surrogate Marker To Predict Susceptibility and Resistance to Voriconazole among 13,338 Clinical Isolates of Candida spp. Tested by Clinical and Laboratory Standards Institute-Recommended Broth Microdilution Methods

  2006cited by this paper
• Interpretive Breakpoints for Fluconazole and Candida Revisited: a Blueprint for the Future of Antifungal Susceptibility Testing

  2006cited by this paper
• Statistical Analyses of Correlation between Fluconazole MICs for Candida spp. Assessed by Standard Methods Set Forth by the European Committee on Antimicrobial Susceptibility Testing (E.Dis. 7.1) and CLSI (M27-A2)

  2006cited by this paper
• Correlation of MIC with Outcome for Candida Species Tested against Voriconazole: Analysis and Proposal for Interpretive Breakpoints

  2006cited by this paper
• Interlaboratory Study of Quality Control Isolates for a Broth Microdilution Method (Modified CLSI M38-A) for Testing Susceptibilities of Dermatophytes to Antifungals

  2006cited by this paper
• Quality Control Limits for Posaconazole Disk Susceptibility Tests on Mueller-Hinton Agar with Glucose and Methylene Blue

  2006cited by this paper
• Evaluation of Amphotericin B Interpretive Breakpoints for Candida Bloodstream Isolates by Correlation with Therapeutic Outcome

  2006cited by this paper
• A Modified Christensen's Urea and CLSI Broth Microdilution Method for Testing Susceptibilities of Six Malassezia Species to Voriconazole, Itraconazole, and Ketoconazole

  2006cited by this paper
• Quality Control and Reference Guidelines for CLSI Broth Microdilution Susceptibility Method (M38-A Document) for Amphotericin B, Itraconazole, Posaconazole, and Voriconazole

  2005cited by this paper
• Quality Control Parameters for Broth Microdilution Tests of Anidulafungin

  2004cited by this paper
• Quality Control Limits for Voriconazole Disk Susceptibility Tests on Mueller-Hinton Agar with Glucose and Methylene Blue

  2004cited by this paper
• Comparison of the Sensititre YeastOne Colorimetric Antifungal Panel with a Modified NCCLS M38-A Method To Determine the Activity of Voriconazole against Clinical Isolates of Aspergillus spp

  2004cited by this paper
• Interlaboratory Comparison of Results of Susceptibility Testing with Caspofungin against Candida and Aspergillus Species

  2004cited by this paper
• Intra- and Interlaboratory Study of a Method for Testing the Antifungal Susceptibilities of Dermatophytes

  2004cited by this paper
• Cross-Resistance between Fluconazole and Ravuconazole and the Use of Fluconazole as a Surrogate Marker To Predict Susceptibility and Resistance to Ravuconazole among 12,796 Clinical Isolates of Candida spp

  2004cited by this paper
• Evaluation of Broth Microdilution Testing Parameters and Agar Diffusion Etest Procedure for Testing Susceptibilities of Aspergillus spp. to Caspofungin Acetate (MK-0991)

  2003cited by this paper
• Comparison of the Sensititre YeastOne colorimetric antifungal panel and Etest with the NCCLS M38-A method to determine the activity of amphotericin B and itraconazole against clinical isolates of Aspergillus spp.

  2003cited by this paper
• Quality Control Limits for Fluconazole Disk Susceptibility Tests on Mueller-Hinton Agar with Glucose and Methylene Blue

  2003cited by this paper
• Minimum fungicidal concentrations of amphotericin B for bloodstream Candida species.

  2003cited by this paper
• Has antifungal susceptibility testing come of age?

  2002cited by this paper
• Testing Conditions for Determination of Minimum Fungicidal Concentrations of New and Established Antifungal Agents for Aspergillus spp.: NCCLS Collaborative Study

  2002cited by this paper
• Optimal Testing Conditions for Determining MICs and Minimum Fungicidal Concentrations of New and Established Antifungal Agents for Uncommon Molds: NCCLS Collaborative Study

  2002cited by this paper
• In Vitro Susceptibility Testing Methods for Caspofungin against Aspergillus andFusarium Isolates

  2001cited by this paper
• Comparison of the E-test with the NCCLS M38-P Method for Antifungal Susceptibility Testing of Common and Emerging Pathogenic Filamentous Fungi

  2001cited by this paper
• Optimal Susceptibility Testing Conditions for Detection of Azole Resistance in Aspergillus spp.: NCCLS Collaborative Evaluation

  2001cited by this paper
• Quality Control Limits for Broth Microdilution Susceptibility Tests of Ten Antifungal Agents

  2000cited by this paper
• Fluconazole Susceptibilities of Bloodstream Candidasp. Isolates as Determined by National Committee for Clinical Laboratory Standards Method M27-A and Two Other Methods

  1999cited by this paper
• Multicenter Comparison of the Sensititre YeastOne Colorimetric Antifungal Panel with the National Committee for Clinical Laboratory Standards M27-A Reference Method for Testing Clinical Isolates of Common and Emerging Candidaspp., Cryptococcus spp., and Other Yeasts and Yeast-Like Organisms

  1999cited by this paper
• Optimizing the Correlation between Results of Testing In Vitro and Therapeutic Outcome In Vivo for Fluconazole by Testing Critical Isolates in a Murine Model of Invasive Candidiasis

  1998cited by this paper
• Interpretation of Trailing Endpoints in Antifungal Susceptibility Testing by the National Committee for Clinical Laboratory Standards Method

  1998cited by this paper
• Comparison of In Vitro Activities of the New Triazole SCH56592 and the Echinocandins MK-0991 (L-743,872) and LY303366 against Opportunistic Filamentous and Dimorphic Fungi and Yeasts

  1998cited by this paper
• Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and candida infections. Subcommittee on Antifungal Susceptibility Testing of the National Committee for Clinical Labora

  1997cited by this paper
• Multicenter evaluation of proposed standardized procedure for antifungal susceptibility testing of filamentous fungi

  1997cited by this paper
• Comparative and collaborative evaluation of standardization of antifungal susceptibility testing for filamentous fungi

  1995cited by this paper
• Morphological effects of lipopeptides against Aspergillus fumigatus correlate with activities against (1,3)-beta-D-glucan synthase

  1994cited by this paper
• National Committee for Clinical Laboratory Standards.

  1980cited by this paper
• Manual of clinical microbiology

  1975cited by this paper

• Thiazolidinone Derivatives as Next-Generation Antifungal Scaffolds: Synthesis and QSAR Study

  2025cites this paper
• Discovery of a potent, broad-spectrum and in vivo effective deuterated tetrazole CYP51 inhibitor.

  2025cites this paper
• Design and Synthesis of Novel Dihydronaphthalene-Based Triazole Scaffolds as Potential Antimicrobial Agents

  2025cites this paper
• Approaches for identifying and measuring heteroresistance in azole-susceptible Candida isolates

  2024cites this paper
• Botrytis cinerea: acetylcholinesterase inhibition, cytotoxicity, antimicrobial, larvicidal activity and metabolite isolated from fungal extract

  2024cites this paper
• Comparing the Anti-candidal Effect of Egg White (Machine and Local) with Amphotericin B in Vitro

  2024cites this paper
• Identification of novel and potent triazoles targeting CYP51 for antifungal: Design, synthesis, and biological study.

  2024cites this paper
• Discovery of highly potent triazole derivatives with broad-spectrum antifungal activity based on Iodiconazole.

  2024cites this paper
• The Most Common Isolated Pathogen Bacteria from Post-Surgical Operation Cases

  2024cites this paper
• Antifungal Susceptibility Testing for Microsporum canis from Cats in Japan.

  2023cites this paper
• Small molecules restore azole activity against drug-tolerant and drug-resistant Candida isolates

  2023cites this paper
• Enhancing the Antifungal Efficacy of Fluconazole with a Diterpene: Abietic Acid as a Promising Adjuvant to Combat Antifungal Resistance in Candida spp.

  2023cites this paper
• In vitro effects of omeprazole in combination with antifungal compounds against Malassezia pachydermatis

  2023cites this paper
• Investigating the Anti-fungal Activity of Different Concentrations of Aloe vera in Candida albicans Infection under In Vitro Conditions

  2023cites this paper
• Effect of Ionic Liquids on Mechanical, Physical, and Antifungal Properties and Biocompatibility of a Soft Denture Lining Material

  2023cites this paper
• Clinical and Microbiological Characteristics of Candidemia Cases in Saudi Arabia

  2023cites this paper
• Syzygium aromaticum extracts debilitate Candida albicans by radically inhibiting its morphological plasticity and biofilm formation

  2023cites this paper
• Anti-multidrug-resistant Staphylococcus aureus and anti-dermatophyte activities of secondary metabolites of the endophytic fungus Penicillium brevicompactum ANT13 associated with the Algerian endemic plant Abies numidica

  2023cites this paper
• Combination of response surface methodology and UPLC-QTOF-MSE for phenolic compounds analysis from Cinnamomum cassia bark as a novel antifungal agent

  2023cites this paper
• High-Throughput Monitoring of Pathogenic Fungal Growth Using Whole Slide Imaging for Rapid Antifungal Susceptibility Assessment

  2023cites this paper
• Antifungal Constituents of Piper crocatum and Their Activities as Ergosterol Biosynthesis Inhibitors Discovered via In Silico Study Using ADMET and Drug-Likeness Analysis

  2023cites this paper
• Genomewide Analysis and Biological Characterization of Cathelicidins with Potent Antimicrobial Activity and Low Cytotoxicity from Three Bat Species

  2022cites this paper
• Malassezia: Zoonotic Implications, Parallels and Differences in Colonization and Disease in Humans and Animals

  2022cites this paper
• Isolation of antifungal-resistant Candida from the blowholes of captive dolphins

  2022influential citation
• The Antifungal and Antibiofilm Activities of Caffeine against Candida albicans on Polymethyl Methacrylate Denture Base Material

  2022cites this paper
• Inactivation of SARS-CoV-2 by a chitosan/α-Ag2WO4 composite generated by femtosecond laser irradiation

  2022cites this paper
• Novel series of N-acyl substituted indole based piperazine, thiazole and tetrazoles as potential antibacterial, antifungal, antioxidant and cytotoxic agents, and their docking investigation as potential Mcl-1 inhibitors.

  2022cites this paper
• Design, synthesis, and evaluation of novel 3-thiophene derivatives as potent fungistatic and fungicidal reagents based on a conformational restriction strategy.

  2022cites this paper
• Selection of an Appropriate In Vitro Susceptibility Test for Assessing Anti-Pythium insidiosum Activity of Potassium Iodide, Triamcinolone Acetonide, Dimethyl Sulfoxide, and Ethanol

  2022cites this paper
• A comparative GC–MS analysis of bioactive secondary metabolites produced by halotolerant Bacillus spp. isolated from the Great Sebkha of Oran

  2021cites this paper
• Reversal of Azole Resistance in Candida albicans by Oridonin.

  2021cites this paper
• Aktivitas Antijamur Ekstrak Etanol Daun Cengkodok (Melastoma malabathricum) Terhadap Pertumbuhan Malassezia furfur

  2021cites this paper
• Respiratory Fungal Infections in Bottlenose Dolphins (Tursiops truncatus)

  2021cites this paper
• Molecular typing and antifungal drug susceptivity profile of Rhodotorula mucilaginosa from canine skin and ear canal

  2021influential citation
• Electroanalysis of Candida albicans biofilms: A suitable real-time tool for antifungal testing

  2021cites this paper
• Antifungal susceptibility of dermatophytes from racehorses in Japan.

  2021cites this paper
• Isolation of antifungal-resistant yeasts from bulk milk in Japan

  2021cites this paper
• Prevalence, Species Distribution and Antifungal Susceptibility Profile of Candida Species Isolated from Bloodstream of Critical Care Unit Patients in a Tertiary Care Hospital in Kenya

  2021influential citation
• Silver Nanoantibiotics Display Strong Antifungal Activity Against the Emergent Multidrug-Resistant Yeast Candida auris Under Both Planktonic and Biofilm Growing Conditions

  2020cites this paper
• Antifungal Susceptibility of Clinical Isolates and Artificially Produced Multi-azole-resistant Strains of Cryptococcus neoformans (formerly: Cryptococcus grubii) to Ravuconazole.

  2020cites this paper
• Antifungal Resistance Regarding Malassezia pachydermatis: Where Are We Now?

  2020influential citation
• First reported case of Gilbertella persicaria in human stool: outcome of a community study from Segamat, Johor, Malaysia

  2020cites this paper
• Comparative evaluation of E-test and CLSI methods for Itraconazole, Fluconazole and Ketoconazole susceptibilities of Microsporum canis strains

  2020cites this paper
• Azoles resistance reversal by oridonin in Candida albicans

  2020cites this paper
• Systemic Inonotus sp. Infection in a dog

  2020cites this paper
• Review of methods and antimicrobial agents for susceptibility testing against Pythium insidiosum

  2020cites this paper
• In vitro algaecid effect of itraconazole and ravuconazole on Prototheca species.

  2019cites this paper
• First isolation of voriconazole-resistant Candida albicans, C. tropicalis, and Aspergillus niger from the blowholes of bottlenose dolphins (Tursiops truncatus)

  2019influential citation
• In vitro ravuconazole susceptibility of anthropophilic dermatophyte strains from Japanese patients.

  2019cites this paper
• Résistance des micromycètes aux antifongiques

  2019cites this paper
• Design, synthesis and evaluation of biphenyl imidazole analogues as potent antifungal agents.

  2019cites this paper
• CLINICAL PRESENTATIONS, DIAGNOSTIC DILEMMA, AND MANAGEMENT OUTCOMES OF CHRONIC POSTOPERATIVE ENDOPHTHALMITIS CAUSED BY STEPHANOASCUS CIFERRII.

  2018cites this paper
• Therapy and Antifungal Susceptibility Profile of Microsporum canis

  2018cites this paper
• Identification of GXXXXG motif in Chrysophsin-1 and its implication in the design of analogs with cell-selective antimicrobial and anti-endotoxin activities

  2017cites this paper
• Amphotericin B fungicidal activity: a comprehensive analysis of fungal recovery

  2017cites this paper
• Susceptibility of Malassezia pachydermatis to aminoglycosides

  2017cites this paper
• Combinatorial strategies for combating invasive fungal infections

  2017cites this paper
• In vitro susceptibility testing of Malassezia pachydermatis to gentamicin

  2017cites this paper
• Selective phenylalanine to proline substitution for improved antimicrobial and anticancer activities of peptides designed on phenylalanine heptad repeat.

  2017cites this paper
• Quantification of CDR1 Gene Expression in Fluconazole Resistant Candida Glabrata Strains Using Real-time PCR

  2017cites this paper
• Methodological Issues in Antifungal Susceptibility Testing of Malassezia pachydermatis

  2017influential citation
• Identification and characterization of an anti-oxidative stress-associated mutant of Aspergillus fumigatus transformed by Agrobacterium tumefaciens

  2016cites this paper
• Antifungal Susceptibility Testing: Evolution, Indications, and Role in Clinical Practice

  2015cites this paper
• The first case of feline sinonasal aspergillosis due to Aspergillus fischeri in Japan

  2015cites this paper
• A flow cytometry method for testing the susceptibility of Cryptococcus spp. to amphotericin B.

  2015cites this paper
• AKTIVITAS ANTIJAMUR INFUSA DAUN SIRSAK TERHADAP CANDIDA ALBICANS

  2015cites this paper
• Efficacy of oleylphosphocholine (OlPC) in vitro and in a mouse model of invasive aspergillosis

  2015cites this paper
• Agar Diffusion Procedures for Susceptibility Testing of Malasseziapachydermatis: Evaluation of Mueller-Hinton Agar Plus 2 % Glucose and 0.5 µg/ml Methylene Blue as the Test Medium

  2015cites this paper
• Animal models of invasive aspergillosis for drug discovery.

  2014cites this paper
• Nepenthes rafflesiana pitcher liquid has antifungal activity against Candida spp.

  2014influential citation
• Nutrient-Dependent Efficacy of the Antifungal Protein YvgO Correlates to Cellular Proliferation Rate in Candida albicans 3153A and Byssochlamys fulva H25

  2014cites this paper
• Hexane neem leaf extract more potent than ethanol extract against Aspergillus flavus

  2014cites this paper
• Pyrrolo[1,2-α][1,4]benzodiazepines show potent in vitro antifungal activity and significant in vivo efficacy in a Microsporum canis dermatitis model in guinea pigs.

  2014cites this paper
• The evaluation of the combination of caspofungin with voriconazole and amphotericin B against clinical Candida krusei isolates by etest and disk diffusion methods.

  2014cites this paper
• In Vitro Antifungal Susceptibility of Malassezia pachydermatis Strains Isolated from Dogs with Chronic and Acute Otitis Externa

  2014cites this paper
• Post-mortem analysis of Candida albicans breakthrough infection during echinocandin treatment in haematopoietic stem cell transplant recipient.

  2014cites this paper
• Susceptibility Breakpoints for Amphotericin B and Aspergillus Species in an In Vitro Pharmacokinetic-Pharmacodynamic Model Simulating Free-Drug Concentrations in Human Serum

  2014cites this paper
• Dermatophytes and related keratinophilic fungi isolated from the soil in Gwalior region of India and in vitro evaluation of antifungal activity of the selected plant extracts against these fungi

  2013cites this paper
• The Relevance of Susceptibility Tests, Breakpoints, and Markers

  2013cites this paper
• Antifungal susceptibility of Malassezia pachydermatis biofilm.

  2013cites this paper
• RELATÓRIO INTEGRADOR DA ACTIVIDADE PROFISSIONAL

  2013cites this paper
• In Vitro Susceptibility of Malassezia pachydermatis Isolates from Canine Skin with Atopic Dermatitis to Ketoconazole and Itraconazole in East Asia

  2013cites this paper
• Emergence of Aspergillus calidoustus Infection in the Era of Posttransplantation Azole Prophylaxis

  2012cites this paper
• Neonatal invasive candidiasis in Tunisian hospital: incidence, risk factors, distribution of species and antifungal susceptibility

  2012cites this paper
• Calcineurin Is Required for Pseudohyphal Growth, Virulence, and Drug Resistance in Candida lusitaniae

  2012cites this paper
• In vitro evaluation of Malassezia pachydermatis susceptibility to azole compounds using E-test and CLSI microdilution methods.

  2012cites this paper
• Calcofluor White Combination Antifungal Treatments for Trichophyton rubrum and Candida albicans

  2012cites this paper
• Lo que debemos saber sobre los métodos de sensibilidad a los antifúngicos What we must know about antifungal suceptibility testing

  2012cites this paper
• In vitro activities of antifungal agents against clinical isolates of dermatophytes from animals.

  2012cites this paper
• Evaluation of the antifungal susceptibility of Malassezia pachydermatis to clotrimazole, miconazole and thiabendazole using a modified CLSI M27-A3 microdilution method.

  2012cites this paper
• Assessment of the antifungal susceptibility of Malassezia pachydermatis in various media using a CLSI protocol.

  2012influential citation
• In vitro antifungal susceptibility of Malassezia pachydermatis from dogs with and without skin lesions.

  2012cites this paper
• REPUBLIQUE ALGERIENNE DEMOCRATIQUE ET POPULAIRE MINISTERE DE L'ENSEIGNEMENT SUPERIEUR ET DE LA RECHERCHE SCIENTIFIQUE

  2012cites this paper
• Risk factors for candidemia with non-albicans Candida spp. in intensive care unit patients with end-stage renal disease on chronic hemodialysis.

  2012cites this paper
• [Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC) guidelines for the diagnosis of invasive fungal infections. 2010 update].

  2011cites this paper
• Recomendaciones sobre el diagnóstico de la enfermedad fúngica invasora de la Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica (SEIMC). Actualización 2010

  2011cites this paper
• Antifungal Susceptibility Tests

  2011cites this paper
• Pharmacodynamic effects of simulated standard doses of antifungal drugs against Aspergillus 1

  2011cites this paper
• Antifongigramme et concentration minimale inhibitrice

  2011cites this paper
• Impact de la consommation d'antifongiques sur Candida sp. : étude dans un service de réanimation médicale de 2004 à 2009 au CHU de Grenoble

  2011cites this paper